NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001643

Registered date:19/01/2009

Trial of Proteinuria Reduction Effect of Losartan/Hydrochlorothiazide Therapy to Chronic Kidney Disease with Hypertension

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic kidney disease patients with hypertension
Date of first enrollment2009/01/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)ARB/hydrochlorothiazide combination drug ARB

Outcome(s)

Primary OutcomeThe primary end point is change in the Up:Ucr ratio from baseline to month 12.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients with uncontrolled hypertension, serum patassium >5.5 mEq/L, cardiovascular disease (myocardial infarction, unstable angina, stroke within last 3 months), pregnancy,lactation,nephrotic syndrome (serum Alb <2g/dl), frequent users of diuretics are excluded.

Related Information

Contact

public contact
Name Kiichiro Fujisaki
Address 3-1-1 Maidashi, higashi-ku Fukuoka Japan
Telephone 092-642-5843
E-mail
Affiliation Kyushu University Hospital Kidney Care Unit
scientific contact
Name Kazuhiko Tsuruya
Address 3-1-1 Maidashi, higashi-ku Fukuoka Japan
Telephone 092-642-5843
E-mail
Affiliation Kyushu University Department of integrated therapy for chronic kidney disease graduate school of medical sciences